
Isis A. D. Ghali
Examiner (ID: 16206, Phone: (571)272-0595 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611, 1615 |
| Total Applications | 1721 |
| Issued Applications | 502 |
| Pending Applications | 316 |
| Abandoned Applications | 934 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13914973
[patent_doc_number] => 10201582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Compositions and methods for alleviating hyposalivation and for providing oral comfort
[patent_app_type] => utility
[patent_app_number] => 15/422772
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6746
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15422772
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/422772 | Compositions and methods for alleviating hyposalivation and for providing oral comfort | Feb 1, 2017 | Issued |
Array
(
[id] => 12165323
[patent_doc_number] => 09884082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Compositions and methods for alleviating hyposalivation and for providing oral comfort'
[patent_app_type] => utility
[patent_app_number] => 15/422732
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7334
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15422732
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/422732 | Compositions and methods for alleviating hyposalivation and for providing oral comfort | Feb 1, 2017 | Issued |
Array
(
[id] => 13325665
[patent_doc_number] => 20180214370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TOPCOAT FOR LONG-WEAR LIP COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/420888
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15420888
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/420888 | TOPCOAT FOR LONG-WEAR LIP COMPOSITIONS | Jan 30, 2017 | Pending |
Array
(
[id] => 16748745
[patent_doc_number] => 20210100754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => TRANSDERMAL DRUG DELIVERY SYSTEMS WITH FLUOROSILICONE RELEASE LINERS
[patent_app_type] => utility
[patent_app_number] => 16/074099
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074099 | TRANSDERMAL DRUG DELIVERY SYSTEMS WITH FLUOROSILICONE RELEASE LINERS | Jan 30, 2017 | Abandoned |
Array
(
[id] => 11554326
[patent_doc_number] => 20170100573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/385665
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11004
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15385665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/385665 | BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY | Dec 19, 2016 | Abandoned |
Array
(
[id] => 16183472
[patent_doc_number] => 10716764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Transdermal drug delivery method and system
[patent_app_type] => utility
[patent_app_number] => 15/385638
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8720
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15385638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/385638 | Transdermal drug delivery method and system | Dec 19, 2016 | Issued |
Array
(
[id] => 17569950
[patent_doc_number] => 11318204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Composition for intravascular delivery of therapeutic composition
[patent_app_type] => utility
[patent_app_number] => 15/373174
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7644
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15373174
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/373174 | Composition for intravascular delivery of therapeutic composition | Dec 7, 2016 | Issued |
Array
(
[id] => 13548583
[patent_doc_number] => 20180325839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => TRANSDERMAL PATCHES
[patent_app_type] => utility
[patent_app_number] => 15/777481
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777481
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777481 | TRANSDERMAL PATCHES | Nov 21, 2016 | Abandoned |
Array
(
[id] => 11541613
[patent_doc_number] => 20170095438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR TRANSDERMAL OXYBUTYNIN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/348478
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20713
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/348478 | Compositions and methods for unoccluded transdermal oxybutynin therapy | Nov 9, 2016 | Issued |
Array
(
[id] => 16663733
[patent_doc_number] => 10932955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Percutaneous absorption agent delivery device and manufacturing method therefor
[patent_app_type] => utility
[patent_app_number] => 15/774441
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 10494
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774441
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774441 | Percutaneous absorption agent delivery device and manufacturing method therefor | Nov 8, 2016 | Issued |
Array
(
[id] => 15631531
[patent_doc_number] => 10588732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Multipurpose implant with modeled surface structure for soft tissue reconstruction
[patent_app_type] => utility
[patent_app_number] => 15/339805
[patent_app_country] => US
[patent_app_date] => 2016-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 32
[patent_no_of_words] => 9297
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15339805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/339805 | Multipurpose implant with modeled surface structure for soft tissue reconstruction | Oct 30, 2016 | Issued |
Array
(
[id] => 12238565
[patent_doc_number] => 20180071428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'WOUND DRESSING'
[patent_app_type] => utility
[patent_app_number] => 15/560357
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560357
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560357 | WOUND DRESSING | Oct 23, 2016 | Abandoned |
Array
(
[id] => 13519307
[patent_doc_number] => 20180311196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => METHOD FOR IMPROVING WHITE MATTER INTEGRITY IN HYPERPHENYLALANINEMIA AND PHENYLKETONURIA PATIENTS
[patent_app_type] => utility
[patent_app_number] => 15/770100
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770100 | METHOD FOR IMPROVING WHITE MATTER INTEGRITY IN HYPERPHENYLALANINEMIA AND PHENYLKETONURIA PATIENTS | Oct 23, 2016 | Abandoned |
Array
(
[id] => 13504429
[patent_doc_number] => 20180303757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => ENHANCED ABUSE-DETERRENT FORMULATIONS OF OXYCODONE
[patent_app_type] => utility
[patent_app_number] => 15/770021
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770021 | ENHANCED ABUSE-DETERRENT FORMULATIONS OF OXYCODONE | Oct 20, 2016 | Abandoned |
Array
(
[id] => 13519251
[patent_doc_number] => 20180311168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => SOLID FORMULATION
[patent_app_type] => utility
[patent_app_number] => 15/769514
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769514
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769514 | Solid formulation | Oct 19, 2016 | Issued |
Array
(
[id] => 11434684
[patent_doc_number] => 20170035704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'Composition for the Transdermal Delivery of Fentanyl'
[patent_app_type] => utility
[patent_app_number] => 15/298891
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13145
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15298891
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/298891 | Composition for the Transdermal Delivery of Fentanyl | Oct 19, 2016 | Abandoned |
Array
(
[id] => 11961962
[patent_doc_number] => 20170266115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/295881
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15513
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295881 | PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF | Oct 16, 2016 | Abandoned |
Array
(
[id] => 11527189
[patent_doc_number] => 20170087167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'MODIFICATION OF DRUGS FOR INCORPORATION INTO NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/280010
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13783
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280010
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/280010 | MODIFICATION OF DRUGS FOR INCORPORATION INTO NANOPARTICLES | Sep 28, 2016 | Abandoned |
Array
(
[id] => 11527201
[patent_doc_number] => 20170087179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'Thiol and Disulfide-Containing Agents for Increasing Meibomian Gland Lipid Secretion'
[patent_app_type] => utility
[patent_app_number] => 15/279301
[patent_app_country] => US
[patent_app_date] => 2016-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20586
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15279301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/279301 | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion | Sep 27, 2016 | Issued |
Array
(
[id] => 13424715
[patent_doc_number] => 20180263900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => SUSTAINED DRUG-RELEASE CONTACT LENS
[patent_app_type] => utility
[patent_app_number] => 15/761561
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761561 | SUSTAINED DRUG-RELEASE CONTACT LENS | Sep 22, 2016 | Abandoned |